ENTRY       D12279                      Drug
NAME        Mipasetamab (USAN/INN)
FORMULA     C6472H9946N1714O2024S44
EXACT_MASS  145469.5749
MOL_WEIGHT  145559.351
SEQUENCE    (Heavy chain)
            QVQLVESGGG VVQPGRSLRL SCAASGFTFS SYGMSWVRQA PGKGLEWVAT ISSGGSYTYY
            PDSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARHP IYYTYDDTMD YWGQGTTVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCSASSSVS SGNFHWYQQK PGLAPRLLIY RTSNLASGIP
            ARFSGSGSGT DFTLTISSLE PEDFAVYYCQ QWSGYPWTFG GGTKLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H149-H205, H225-L215, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'215, H'266-H'326, H'372-H'430, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-AXL antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of solid tumors
TARGET      AXL [HSA:558] [KO:K05115]
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               AXL family
                AXL
                 D12279  Mipasetamab (USAN/INN)
DBLINKS     CAS: 2361055-48-1
///
